iBio Inc (IBIO)

Jul 25, 2025

iBio Inc. Stock Analysis and ForecastConsistently superior profits - PrintWeekIndia

Jul 25, 2025

Jul 24, 2025

What analysts say about iBio Inc. stockFree Investment Timing Strategies - Autocar Professional

Jul 24, 2025

Jul 23, 2025

What drives iBio Inc. stock priceSkyrocketing profit margins - Autocar Professional

Jul 23, 2025

Jul 22, 2025

Is iBio Inc. a good long term investmentExplosive earning power - jammulinksnews.com

Jul 22, 2025

Jul 19, 2025

how ibio stock performs during market volatilityFree Short-Term Stock Picks - Newser

Jul 19, 2025

Jul 19, 2025

what makes ibio inc. stock price move sharplyFree Step-by-Step Investment Guide - Newser

Jul 19, 2025

Jul 18, 2025

What institutions are buying iBio Inc. stock nowFree Access to Investment Community - Newser

Jul 18, 2025

Jul 15, 2025

Why iBio Inc. stock attracts strong analyst attentionFree Stock Selection with 300% Return - Newser

Jul 15, 2025

Jul 15, 2025

What makes iBio Inc. stock price move sharplyChart Based Entries - Newser

Jul 15, 2025

Jul 15, 2025

IBIO’s Market Whiplash: -61.36% YTD Decline, -20.36% Plunge in 30 Days - investchronicle.com

Jul 15, 2025

Jul 15, 2025

How iBio Inc. stock performs during market volatilityFree Access to Investors Club - Newser

Jul 15, 2025

Jul 11, 2025

iBio (NYSEMKT:IBIO) Stock Price Down 0% – What’s Next? - Defense World

Jul 11, 2025

Jun 25, 2025

iBio (IBIO) Receives Continued "Buy" Rating from Chardan Capital | IBIO Stock News - GuruFocus

Jun 25, 2025

Jun 24, 2025

iBio stock soars after amylin receptor antibody shows promising results - Investing.com

Jun 24, 2025

Jun 24, 2025

iBio Advances Obesity Care with Antibody Therapies - TipRanks

Jun 24, 2025

Jun 24, 2025

iBio (IBIO) Reports Promising Preclinical Results in Obesity Stu - GuruFocus

Jun 24, 2025

Jun 24, 2025

iBio stock soars after amylin receptor antibody shows promising results By Investing.com - Investing.com UK

Jun 24, 2025

Jun 23, 2025

iBio and AstralBio Unveil Obesity Program with Novel Amylin Agon - GuruFocus

Jun 23, 2025

Jun 23, 2025

iBio to host conference call on obesity treatment advances - Investing.com

Jun 23, 2025

Jun 19, 2025

iBio Extends Promissory Note Maturity to 2026 - TipRanks

Jun 19, 2025

Jun 17, 2025

Ibio nominates IBIO-610 as obesity development candidate - BioWorld MedTech

Jun 17, 2025

Jun 16, 2025

iBio initiates primate study for obesity antibody candidate IBIO-610 By Investing.com - Investing.com South Africa

Jun 16, 2025

Jun 16, 2025

iBio (IBIO) Begins Preclinical Study of New Antibody Candidate | - GuruFocus

Jun 16, 2025

Jun 16, 2025

iBio initiates primate study for obesity antibody candidate IBIO-610 - Investing.com

Jun 16, 2025

Jun 16, 2025

iBio Initiates Non-Human Primate Study of First-in-Class Activin E Antibody Following Positive Preclinical Data Demonstrating Prevention in Weight Regain After GLP-1 Treatment | IBIO Stock News - GuruFocus

Jun 16, 2025

Jun 16, 2025

iBio initiates non-human primate study of IBIO-610 - TipRanks

Jun 16, 2025

Jun 16, 2025

iBio Initiates Non-Human Primate Study of First-in-Class Activin E Antibody Following Positive Preclinical Data Demonstrating Prevention in Weight Regain After GLP-1 Treatment - The Manila Times

Jun 16, 2025

Jun 16, 2025

Breakthrough Obesity Drug Shows 77% Fat Reduction When Combined With GLP-1 Treatments - Stock Titan

Jun 16, 2025

Jun 13, 2025

iBio (IBIO) Plans to Offer 11.25 Million Shares of Common Stock - GuruFocus

Jun 13, 2025

Jun 13, 2025

Sector Update: Health Care - MarketScreener

Jun 13, 2025

Jun 13, 2025

IBio Files Prospectus for Resale of About 11.3 Million Shares - marketscreener.com

Jun 13, 2025

Jun 10, 2025

Plant-Based Vaccines Market Future Business Opportunities 2025-2032 | Medicago, Inc., IBIO, Icon Genetics GmbH - newstrail.com

Jun 10, 2025

May 29, 2025

iBio: University of Limerick programme to ‘shape the next generation’ of pharmaceutical manufacturing experts - University of Limerick

May 29, 2025